APREA THERAPEUTICS, INC. (APRE)
Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
The State of Americas Rare Earth Supply Chain in 2026 - OilPrice.com Market Commentary
Extendicare Announces March 2026 Dividend of C$0.0441 per Share
New Two-Year Data from Pivotal ApproaCH Trial Showing Durable Benefits of TransCon® CNP (Navepegritide) in Children with Achondroplasia Shared at ACMG 2026
Concerned Shareholders of Oportun Financial Corporation Call for Board Member Ginny Lee to Resign Immediately
Koppers Management Participating in Sidoti Small Cap Conference
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
Jiuzi Holdings and AetheriumX Sign Strategic MOU for $30M Investment into Web3
POET Technologies and LITEON Announce Joint Development of Optical Modules for AI Applications
Equinor ASA: Notifiable trading